Findings from Stanford University Provide New Insights into B-Cell Lymphoma (Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma)

  • Hrishikesh Srinagesh

Press/Media

Period12 Jul 2024

Media coverage

1

Media coverage

  • TitleFindings from Stanford University Provide New Insights into B-Cell Lymphoma (Bendamustine is a safe and effective lymphodepletion agent for axicabtagene ciloleucel in patients with refractory or relapsed large B-cell lymphoma)
    Media name/outletCancer Gene Therapy Daily
    Country/TerritoryUnited States
    Date12/07/24
    PersonsHrishikesh Srinagesh